Recent Quotes (30 days)

You have no recent quotes
chg | %

Bio-Rad Laboratories, Inc.  

(Public, NYSE:BIO)   Watch this stock  
Find more results for BIO
256.75
+1.26 (0.49%)
Real-time:   10:04AM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 255.48 - 256.98
52 week 169.18 - 268.40
Open 255.48
Vol / Avg. 3,677.00/194,858.00
Mkt cap 8.96B
P/E 321.62
Div/yield     -
EPS 0.80
Shares 29.76M
Beta 0.88
Inst. own 65%
Nov 2, 2017
Q3 2017 Bio Rad Laboratories Inc Earnings Call - Webcast
Nov 2, 2017
Q3 2017 Bio Rad Laboratories Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 5.12% 1.36%
Operating margin 8.67% 2.54%
EBITD margin - 13.10%
Return on average assets 2.64% 0.74%
Return on average equity 3.88% 1.11%
Employees 8,250 -
CDP Score - -

Address

1000 ALFRED NOBEL DR
HERCULES, CA 94547-1811
United States - Map
+1-510-7247000 (Phone)
+1-510-7415817 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. As of December 31, 2016, Bio-Rad sold more than 8,000 products and services to a client base, including scientific research, healthcare, education and government customers around the world.

Officers and directors

Norman D. Schwartz Chairman of the Board, President, Chief Executive Officer
Age: 71
Bio & Compensation  - Reuters
Christine A. Tsingos Chief Financial Officer, Executive Vice President
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John P. Goetz Chief Operating Officer, Executive Vice President
Age: 67
Bio & Compensation  - Reuters
Timothy Scott Ernst Executive Vice President, General Counsel and Secretary
Age: 57
Bio & Compensation  - Reuters
Michael Crowley Executive Vice President, Global Commercial Operations
Age: 55
Bio & Compensation  - Reuters
Shannon Hall Executive Vice President, President, Life Science Group
Age: 47
Bio & Compensation  - Reuters
John Hertia Executive Vice President, President, Clinical Diagnostics Group
Age: 61
Bio & Compensation  - Reuters
Giovanni Magni Executive Vice President, Chief Strategy Officer
Age: 60
Bio & Compensation  - Reuters
Ronald W. Hutton Vice President, Treasurer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alice N. Schwartz Director
Age: 90
Bio & Compensation  - Reuters